Florida Clinical Research Center, LLC
Welcome,         Profile    Billing    Logout  
 3 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Marraffino, Andrea
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

Completed
4
246
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac
Attention Deficit/Hyperactivity Disorder
05/24
05/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Active, not recruiting
4
123
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials
Attention Deficit/Hyperactivity Disorder
07/25
07/25
ADHD, NCT06215144: Study to Evaluate NRCT-101SR in Pediatric Subjects with

Recruiting
2/3
160
US
NRCT-101SR, Matching Placebo
Neurocentria, Inc.
Attention-Deficit/Hyperactivity Disorder (ADHD)
12/25
02/26
NCT06673368: A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder

Recruiting
2
60
US
NRCT-101SR, NRCT-202XR
Neurocentria, Inc.
ADHD
11/25
11/25
Hull, Joseph T
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Marraffino, Andrea
KP415P01, NCT05685732: An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

Completed
4
246
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac
Attention Deficit/Hyperactivity Disorder
05/24
05/24
KP415P02, NCT05721235: A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

Active, not recruiting
4
123
US
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
Corium, Inc., Premier Research Group plc, Prometrika, LLC, Almac, Worldwide Clinical Trials
Attention Deficit/Hyperactivity Disorder
07/25
07/25
ADHD, NCT06215144: Study to Evaluate NRCT-101SR in Pediatric Subjects with

Recruiting
2/3
160
US
NRCT-101SR, Matching Placebo
Neurocentria, Inc.
Attention-Deficit/Hyperactivity Disorder (ADHD)
12/25
02/26
NCT06673368: A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder

Recruiting
2
60
US
NRCT-101SR, NRCT-202XR
Neurocentria, Inc.
ADHD
11/25
11/25
Hull, Joseph T
No trials found

Download Options